NOY

Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia

Product code

NOY

Device name

Agents, Embolic, For Treatment Of Benign Prostatic Hyperplasia

Device class

Class 2

21 CFR

21 CFR 876.5550

Medical specialty

Gastroenterology, Urology

Marketing pathway

510(K)

Flag

Implant

510(k) clearances (all years, FDA)

4 (all years; only the last 3 years are listed here)

FDA classification definition

The device comprises one or more objects placed in a blood vessel to permanently obstruct blood flow to the prostate to treat benign prostatic hyperplasia (BPH).

Definition text from the FDA device classification database (U.S. federal government work, public domain).